The elevated level of IL-1β has been shown to upregulate osteoprotegerin (OPG) expression in the breast cancer cell lines MCF-7 and MDA-MB-231 by activation of p38 and p42/44 MAPK signaling pathway [86]. The gene discussed is IL1B; the disease is breast carcinoma.